Estimated average glucose derived from HbA1c (eAG): Report from European Association for the Study of Diabetes (EASD), Amsterdam 2007

Diabetic Medicine

Volumn 25, Issue 2, 2008, Pages 126-128

  Manley, S E ^a,b  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b SELLY OAK HOSPITAL   (United Kingdom)

Author keywords

Continuous blood glucose monitoring; Estimated average glucose (eAG); HbA1c; International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) reference method; National Glycohemoglobin Standardisation Program (NGSP)

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; COST BENEFIT ANALYSIS; DIABETES MELLITUS; ERYTHROCYTE LIFESPAN; EUROPE; GLUCOSE BLOOD LEVEL; HEALTH CARE ORGANIZATION; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL RESEARCH; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; REFERENCE DATABASE; UNITED STATES;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; RISK FACTORS;

EID: 39749131704     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02383.x     Document Type: Article

References (12)

1. Little RR, Rohlfing CL, Wiedmeyer H-M, Myers GL, Sacks DB, Goldstein DE. The National Glycohemoglobin Standardisation Program: a 5-year progress report. Clin Chem 2001 47 : 1985 1992.
2. 1c and its measurement in the presence of variant haemoglobins: report on questionnaire to manufacturers. Ann Clin Biochem 2006 43 : 135 145.
3. 1c based on peptide mapping. Clin Chem 1997 43 : 1944 1951.
4. 1c in human blood and the national standardization schemes in the USA, Japan, and Sweden: a method-comparison study. Clin Chem 2004 50 : 166 174.
5. 1c measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007 9 : 2399 2400 and Diabetologia 2007 50 : 2042 2043.
6. DCCT Study Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. N Eng J Med 1993 329 : 977 986.
7. UK Prospective Diabetes Study Group. UKPDS 33: intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes. Lancet 1998 352 : 837 853.
8. IDF Clinical Guidelines Task Force. Global guidelines for Type 2 diabetes. Brussels : International Diabetes Federation 2005.
9. 1c in the Diabetes Control and Complications Trial. Diabetes Care 2002 25 : 275 278.
10. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002 48 : 436 472.
11. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995 44 : 968 983.
12. UK Prospective Diabetes Study Group. UKPDS 35 : Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes: prospective observational study. Br Med J 2000 321 : 405 412.